Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Opal Wealth Advisors LLC

Opal Wealth Advisors LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 512 shares of the medical equipment provider’s stock after purchasing an additional 25 shares during the period. Opal Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $267,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Savant Capital LLC grew its position in Intuitive Surgical by 17.8% during the fourth quarter. Savant Capital LLC now owns 6,803 shares of the medical equipment provider’s stock valued at $3,551,000 after acquiring an additional 1,030 shares during the period. Martin Capital Advisors LLP lifted its holdings in shares of Intuitive Surgical by 4.3% during the 4th quarter. Martin Capital Advisors LLP now owns 20,206 shares of the medical equipment provider’s stock valued at $10,547,000 after acquiring an additional 825 shares in the last quarter. Bank of Stockton increased its holdings in Intuitive Surgical by 13.5% in the 4th quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock valued at $606,000 after purchasing an additional 138 shares in the last quarter. Focused Wealth Management Inc purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $218,000. Finally, 17 Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 1.9% during the 4th quarter. 17 Capital Partners LLC now owns 1,851 shares of the medical equipment provider’s stock valued at $966,000 after buying an additional 35 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,671 shares of company stock valued at $3,188,254 in the last three months. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 0.9 %

Shares of NASDAQ:ISRG opened at $582.98 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a market cap of $207.65 billion, a PE ratio of 90.95, a P/E/G ratio of 5.67 and a beta of 1.39. The company’s 50-day moving average price is $554.85 and its 200 day moving average price is $514.38.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of analyst reports. Piper Sandler reiterated an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Royal Bank of Canada raised their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.